Search

Search Constraints

You searched for: Author/Creator Thompson, Philip

Search Results

21. Long‐term follow‐up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic‐phase chronic myeloid leukemia. Issue 1 (25th September 2019)

22. Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis. Issue 11 (27th August 2022)

23. Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. (January 2018)

24. Quantitative disease progression model of α‐1 proteinase inhibitor therapy on computed tomography lung density in patients with α‐1 antitrypsin deficiency. (11th August 2017)

26. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. (28th March 2019)

28. Seasonal-to-interannual prediction of North American coastal marine ecosystems: Forecast methods, mechanisms of predictability, and priority developments. (April 2020)

29. Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies. Issue 11 (November 2018)